Sen. Mike Enzi said he knew of a foundation that would import insulin for patients, but it doesn’t appear to exist.

The FDA has approved more than 1,600 generic drug applications since January 2017 — about a third more than it did in the last two years of the Obama administration. But more than 700, or about 43%, of those generics still weren't on the market as of early January.

While appetite for policymaking is on the upswing, the details of a possible solution remain up in the air. The administration hasn't outlined a detailed plan. But key lawmakers have met with officials to discuss how to reduce costs.

Researchers looked at marketing of short-term plans, which don’t have to meet most ACA provisions. Regardless of the search term used, companies promoting or selling only these kinds of plans dominated the results.